Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 98 citing McNulty: A randomized trial of sibutramine in the management of obese type 2 diabetic patients.... (0.17 sec) 

Meta-analysis: pharmacologic treatment of obesity


Z Li, M Maglione, W Tu, W Mojica, D … - Annals of internal …, 2005 - Am Coll Physicians
Background: In response to the increase in obesity, pharmacologic treatments for weight loss
have become more numerous and more commonly used. ... Purpose: To assess the efficacy
and safety of weight loss medications approved by the US Food and Drug Administration ...
Cited by 327 - Related articles - BL Direct - All 8 versions

Screening and interventions for obesity in adults: summary of the evidence for the …


KM McTigue, R Harris, B Hemphill, L Lux, S … - Annals of Internal …, 2003 - Am Coll Physicians
Background: Obesity poses a considerable and growing health burden. This review examines
evidence for screening and treating obesity in adults. ... Data Sources: MEDLINE and Cochrane
Library (January 1994 through February 2003). ... Study Selection: Systematic reviews; ...
Cited by 322 - Related articles - BL Direct - All 12 versions

Drug treatments for obesity: orlistat, sibutramine, and rimonabant


RS Padwal, SR Majumdar - The Lancet, 2007 - Elsevier
Antiobesity treatment is recommended for selected patients in whom lifestyle modification is
unsuccessful. Two antiobesity drugs are currently licensed for long-term use. Orlistat, a gastrointestinal
lipase inhibitor, reduces weight by around 3 kg on average and decreases progression to ...
Cited by 212 - Related articles - All 11 versions

The efficacy and safety of sibutramine for weight loss: a systematic review


DE Arterburn, PK Crane, DL Veenstra - Archives of Internal …, 2004 - archinte.highwire.org
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ...
Cited by 177 - Related articles - BL Direct - All 5 versions

Obesity in older adults: technical review and position statement of the American …


DT Villareal, CM Apovian, RF Kushner, S … - American Journal of …, 2005 - ajcn.cnfindpark.cn
Obesity causes serious medical complications and impairs quality of life. Moreover, in older
persons, obesity can exacerbate the age-related decline in physical function and lead to
frailty. However, appropriate treatment for obesity in older persons is controversial ...
Cited by 146 - Related articles - BL Direct - All 12 versions

A review of the metabolic effects of sibutramine


TD Filippatos, DN Kiortsis, EN … - Current Medical …, 2005 - informahealthcare.com
(University of London), Royal Free Campus, London, UK Campus, London, UK ... Address for
correspondence: Professor Moses S. Elisaf, Department of Internal Medicine, ses S. Elisaf, Department
of In rtment of Internal Medic ment of Internal Medicine, nt of Internal Medicine, nternal ...
Cited by 63 - Related articles - All 11 versions

Prediction of successful weight reduction under sibutramine therapy through …


H Hauner, M Meier, KH Jöckel, UH Frey, W … - Pharmacogenetics and …, 2003 - journals.lww.com
Background Sibutramine, a centrally acting noradrenaline and serotonin re-uptake inhibitor,
enhances satiety and is frequently used to support weight loss. However, a significant variability
exists among individuals concerning the response to sibutramine.
Cited by 58 - Related articles - BL Direct - All 7 versions

Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and …

- ahajournals.org
KM Gadde, DB Allison - Circulation, 2006 - Am Heart Assoc
The prevalence of obesity has risen substantially during the past 25 years in the United States
and most developed countries, with a related increase in type 2 diabetes mellitus. 1,2 Almost
one third of the adult US population is considered to be obese (body mass index [BMI] ...
Cited by 40 - Related articles - All 4 versions

Cannabinoids and the regulation of ingestive behaviour


SP Vickers, GA Kennett - Current Drug Targets, 2005 - ingentaconnect.com
Abstract: Over past centuries, Cannabis sativa (∆ 9 -tetrahydrocannabinol being the principal
active ingredient) has been used extensively for both medicinal and recreational uses, and one
widely reported effect is the onset of a ravenous appetite and eating behaviour. The ...
Cited by 39 - Related articles - All 2 versions

Obesity and pharmacologic therapy


M Thearle, LJ Aronne - Endocrinology and metabolism clinics of North America, 2003 - Elsevier
The prevalence of obesity continues to rise in developed nations. Potential contributing factors
include easy access to highly palatable and energy-dense foods, a sedentary lifestyle, and a
genetic legacy to preferentially store energy. According to National Health and Nutrition ...
Cited by 39 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google